364 related articles for article (PubMed ID: 30165605)
1. Long-term Stability of Resistance to Latent Mycobacterium tuberculosis Infection in Highly Exposed Tuberculosis Household Contacts in Kampala, Uganda.
Stein CM; Nsereko M; Malone LL; Okware B; Kisingo H; Nalukwago S; Chervenak K; Mayanja-Kizza H; Hawn TR; Boom WH
Clin Infect Dis; 2019 May; 68(10):1705-1712. PubMed ID: 30165605
[TBL] [Abstract][Full Text] [Related]
2. Discordance between TST and QFT-TBGold Plus for Latent Tuberculosis Screening among Under-Five Children: An Interim Analysis.
Surve S; Bhor V; Naukariya K; Begum S; Munne K; Tipre P; Sutar N; Jaiswal A; Bhonde G; Chauhan S; Shah I
J Trop Pediatr; 2021 Dec; 67(6):. PubMed ID: 34904674
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
[TBL] [Abstract][Full Text] [Related]
4. Accurate diagnosis of latent tuberculosis in children, people who are immunocompromised or at risk from immunosuppression and recent arrivals from countries with a high incidence of tuberculosis: systematic review and economic evaluation.
Auguste P; Tsertsvadze A; Pink J; Court R; Seedat F; Gurung T; Freeman K; Taylor-Phillips S; Walker C; Madan J; Kandala NB; Clarke A; Sutcliffe P
Health Technol Assess; 2016 May; 20(38):1-678. PubMed ID: 27220068
[TBL] [Abstract][Full Text] [Related]
5. Implementing contact tracing for tuberculosis in Kyrgyz Republic and risk factors for positivity using QuantiFERON-TB Gold plus.
Corbett C; Kulzhabaeva A; Toichkina T; Kalmambetova G; Ahmedov S; Antonenka U; Iskakova A; Kosimova D; Migunov D; Myrzaliev B; Sahalchyk E; Umetalieva N; Vogel M; Kadyrov A; Hoffmann H
BMC Infect Dis; 2020 Oct; 20(1):746. PubMed ID: 33046016
[TBL] [Abstract][Full Text] [Related]
6. Tuberculin skin testing and treatment modulates interferon-gamma release assay results for latent tuberculosis in migrants.
O'Shea MK; Fletcher TE; Beeching NJ; Dedicoat M; Spence D; McShane H; Cunningham AF; Wilson D
PLoS One; 2014; 9(5):e97366. PubMed ID: 24816576
[TBL] [Abstract][Full Text] [Related]
7. Tuberculin skin test and QuantiFERON-Gold In Tube assay for diagnosis of latent TB infection among household contacts of pulmonary TB patients in high TB burden setting.
Chandrasekaran P; Mave V; Thiruvengadam K; Gupte N; Shivakumar SVBY; Hanna LE; Kulkarni V; Kadam D; Dhanasekaran K; Paradkar M; Thomas B; Kohli R; Dolla C; Bharadwaj R; Sivaramakrishnan GN; Pradhan N; Gupte A; Murali L; Valvi C; Swaminathan S; Gupta A;
PLoS One; 2018; 13(8):e0199360. PubMed ID: 30067752
[TBL] [Abstract][Full Text] [Related]
8. Relating Tuberculosis (TB) Contact Characteristics to QuantiFERON-TB-Gold and Tuberculin Skin Test Results in the Toronto Pediatric TB Clinic.
Rose W; Read SE; Bitnun A; Rea E; Stephens D; Pongsamart W; Kitai I
J Pediatric Infect Dis Soc; 2015 Jun; 4(2):96-103. PubMed ID: 26407408
[TBL] [Abstract][Full Text] [Related]
9. Screening for latent tuberculosis in Norwegian health care workers: high frequency of discordant tuberculin skin test positive and interferon-gamma release assay negative results.
Gran G; Aßmus J; Dyrhol-Riise AM
BMC Public Health; 2013 Apr; 13():353. PubMed ID: 23590619
[TBL] [Abstract][Full Text] [Related]
10. Infection free "resisters" among household contacts of adult pulmonary tuberculosis.
Mave V; Chandrasekaran P; Chavan A; Shivakumar SVBY; Danasekaran K; Paradkar M; Thiruvengadam K; Kinikar A; Murali L; Gaikwad S; Hanna LE; Kulkarni V; Pattabiraman S; Suryavanshi N; Thomas B; Kohli R; Sivaramakrishnan GN; Pradhan N; Bhanu B; Kagal A; Golub J; Gandhi N; Gupte A; Gupte N; Swaminathan S; Gupta A;
PLoS One; 2019; 14(7):e0218034. PubMed ID: 31318864
[TBL] [Abstract][Full Text] [Related]
11. Comparison of TST and IGRA in Diagnosis of Latent Tuberculosis Infection in a High TB-Burden Setting.
Sharma SK; Vashishtha R; Chauhan LS; Sreenivas V; Seth D
PLoS One; 2017; 12(1):e0169539. PubMed ID: 28060926
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a new interferon gamma release assay, in comparison to tuberculin skin tests and quantiferon tuberculosis goldplus for the detection of latent tuberculosis infection in children from a high tuberculosis burden setting.
Benachinmardi K; Sampath S; Rao M
Int J Mycobacteriol; 2021; 10(2):142-148. PubMed ID: 34558465
[TBL] [Abstract][Full Text] [Related]
13. Dual latent tuberculosis screening with tuberculin skin tests and QuantiFERON-TB assays before TNF-α inhibitor initiation in children in Spain.
Calzada-Hernández J; Anton J; Martín de Carpi J; López-Montesinos B; Calvo I; Donat E; Núñez E; Blasco Alonso J; Mellado MJ; Baquero-Artigao F; Leis R; Vegas-Álvarez AM; Medrano San Ildefonso M; Pinedo-Gago MDC; Eizaguirre FJ; Tagarro A; Camacho-Lovillo M; Pérez-Gorricho B; Gavilán-Martín C; Guillén S; Sevilla-Pérez B; Peña-Quintana L; Mesa-Del-Castillo P; Fortuny C; Tebruegge M; Noguera-Julian A
Eur J Pediatr; 2023 Jan; 182(1):307-317. PubMed ID: 36335186
[TBL] [Abstract][Full Text] [Related]
14. Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study.
Abubakar I; Lalvani A; Southern J; Sitch A; Jackson C; Onyimadu O; Lipman M; Deeks JJ; Griffiths C; Bothamley G; Kon OM; Hayward A; Lord J; Drobniewski F
Health Technol Assess; 2018 Oct; 22(56):1-96. PubMed ID: 30334521
[TBL] [Abstract][Full Text] [Related]
15. Comparison of IGRA tests and TST in the diagnosis of latent tuberculosis infection and predicting tuberculosis in risk groups in Krakow, Poland.
Kruczak K; Duplaga M; Sanak M; Cmiel A; Mastalerz L; Sladek K; Nizankowska-Mogilnicka E
Scand J Infect Dis; 2014 Sep; 46(9):649-55. PubMed ID: 25073535
[TBL] [Abstract][Full Text] [Related]
16. Role of QuantiFERON(®)-TB Gold In-Tube in tuberculosis contact investigation: experience in a tuberculosis unit.
Gonzślez-Moreno J; García-Gasalla M; Gállego-Lezaun C; Fernández-Baca V; Mir Viladrich I; Cifuentes-Luna C; Serrano Bujalance A; Salom Vallespir A; Payeras Cifre A
Infect Dis (Lond); 2015 Apr; 47(4):244-51. PubMed ID: 25692351
[TBL] [Abstract][Full Text] [Related]
17. Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis.
Doan TN; Eisen DP; Rose MT; Slack A; Stearnes G; McBryde ES
PLoS One; 2017; 12(11):e0188631. PubMed ID: 29182688
[TBL] [Abstract][Full Text] [Related]
18. HIV patients with latent tuberculosis living in a low-endemic country do not develop active disease during a 2 year follow-up; a Norwegian prospective multicenter study.
Pullar ND; Steinum H; Bruun JN; Dyrhol-Riise AM
BMC Infect Dis; 2014 Dec; 14():667. PubMed ID: 25515915
[TBL] [Abstract][Full Text] [Related]
19. Comparing interferon-gamma release assays with tuberculin skin test for identifying latent tuberculosis infection that progresses to active tuberculosis: systematic review and meta-analysis.
Auguste P; Tsertsvadze A; Pink J; Court R; McCarthy N; Sutcliffe P; Clarke A
BMC Infect Dis; 2017 Mar; 17(1):200. PubMed ID: 28274215
[TBL] [Abstract][Full Text] [Related]
20. Cost analysis of tuberculin skin test and the QuantiFERON-TB Gold In-tube test for tuberculosis screening in a correctional setting in Dallas, Texas, USA.
Nijhawan AE; Iroh PA; Brown LS; Winetsky D; Porsa E
BMC Infect Dis; 2016 Oct; 16(1):564. PubMed ID: 27733123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
